Volume 46, Issue 4 , Pages 405-409, December 2007
Evaluation of the Results of Cordocentesis
Article Outline
SUMMARY
Objective
To evaluate the results of cordocentesis carried out in our clinic at Meram Medicine Faculty of Selcuk University in Konya, Turkey.
Materials and Methods
Cytogenetic results and complication data were obtained by cordocentesis from 250 pregnancies performed in our clinic.
Results
Adequate amount of cord blood was taken 98% of the time, the successful culture rate was 92.8%, and none of the 18 cases in which no proliferation was detected in the culture accepted a new intervention. Cordocentesis was performed in 14 cases (5.6%), because no results were obtained from amniocentesis carried out for various indications. According to cytogenetic evaluation, chromosomal abnormality was detected in 12 cases (5.17%), including four cases of trisomy 21, four cases of trisomy 18, one case of trisomy 13, one case of triploidy (69,XXX) and two cases of chromosomal inversion. Of the 250 cordocentesis cases, there were 12 (4.8%) cases of fetal loss, including four cases of rupture of membranes, four cases of abdominal pain and vaginal bleeding and four cases of a spontaneous abortus. In 53 (21.2%) cases, cordocentesis was performed because of hydrops fetalis; and of the total 12 losses, six were in this group. The fetal loss rate was 11.32% in the hydrops fetalis group.
Conclusion
If cordocentesis is carried out by highly skilled physicians and optimal culture conditions are available, cordocentesis is an invasive prenatal diagnostic and therapeutic procedure that is performed secondary to amniocentesis with high accuracy and safety. In cases of hydrops fetalis in which cordocentesis is carried out, fetal loss is more likely to occur.
Key Words: cordocentesis , fetal abnormality , hydrops fetalis
No full text is available. To read the body of this article, please view the PDF online.
References
- . Down Syndrome Screening . Washington, DC: ACOG; 1994; ACOG Committee Opinion No. 141
- . Amniocentesis, skin biopsy, umbilical cord blood sampling in the prenatal diagnosis of genetic disorders . In: Reece EA , Hobbins JC , Mahoney MJ editor. Medicine of the Fetus and Mother . Philadelphia: JB Lippincott; 1992;p. 641–652
- . Canadian multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Final report . Prenat Diagn . 1992;12:385–408
- . Complications of fetal blood sampling . Am J Obstet Gynecol . 1993;168:1339–1344
- . Fetal loss rate associated with cordocentesis at midgestation . Am J Obstet Gynecol . 2001;184:719–723
- . Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases . Am J Obstet Gynecol . 1985;153:655–660
- Pure fetal blood samples obtained by cordocentesis: technical aspects of 322 cases . Prenat Diagn . 1990;10:93–100
- . Percutaneous umbilical blood sampling: results from a multicenter collaborative registry. The Western Collaborative Perinatal Group . Am J Obstet Gynecol . 1992;166:1614–1617
- . Rapid karyotyping in non-lethal fetal malformations . Lancet . 1986;1:283–287
- . Karyotyping of at risk fetuses by cor-docentesis in advanced gestation . Indian J Med Res . 1996;104:288–291
- Cordocentesis for rapid karyotyping in fetuses with congenital anomalies or severe IUGR . Eur J Obstet Gynecol Reprod Biol . 1994;53:183–187
- . Cordocentesis at 16–24 weeks of gestation: experience of 1,320 cases . Prenat Diagn . 2000;20:224–228
PII: S1028-4559(08)60011-X
doi:10.1016/S1028-4559(08)60011-X
© 2007 Taiwan Association of Obstetric & Gynecology. Published by Elsevier Inc. All rights reserved.
Volume 46, Issue 4 , Pages 405-409, December 2007
